D. K. Hossfeld

6.3k citations

54 papers · 4.5k indexed · 1 hit paper · h-index 18

Impact in

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment

Papers in

Hematology 20
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 7
- Multiple Myeloma Research and Treatments 4
Genetics 9
- Chronic Lymphocytic Leukemia Research 6

Co-authors: Walter Fiedler H.J. Weh Ulrich Dührsen C. G. Schmidt G. Landbeck K. Mross H. Kabisch Holger Diedrichs
Journals: Annals of Hematology (9 papers)Annals of Oncology (5 papers)Journal of Clinical Oncology (4 papers)British Journal of Haematology (3 papers)Leukemia (3 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

D. K. Hossfeld

53 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2002 · 3.6k citations

Peers

Countries citing papers authored by D. K. Hossfeld

Since Specialization

Citations

This map shows the geographic impact of D. K. Hossfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. K. Hossfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. K. Hossfeld more than expected).

Fields of papers citing papers by D. K. Hossfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. K. Hossfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. K. Hossfeld. The network helps show where D. K. Hossfeld may publish in the future.

Co-authors

The 25 scholars most cited alongside D. K. Hossfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. K. Hossfeld Line = papers co-authored together D. K. Hossfeld links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Behandlung einer thrombotisch-thrombozytopenischen Purpura (Morbus Moschcowitz) mit Vincristin DMW - Deutsche Medizinische Wochenschrift ·Günter Wolf, Friedrich Thaiss, Ulrich Dührsen, H.J. Weh, D. K. Hossfeld, Rolf A.K. Stahl	2008	2
2	Gender aspects in chronic myeloid leukemia: long-term results from randomized studies Leukemia ·Ute Berger, Ole Maywald, Markus Pfirrmann, Tanja Lahaye, Andreas Hochhaus, Andreas Reiter, Joerg Hasford, H. Heimpel, D. K. Hossfeld, H-J Kolb, H. Löffler, H. Pralle, W. Queißer, Rüdiger Hehlmann, (unknown)	2005	54
3	Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases Annals of Hematology ·Florian Länger, Barbara Eifrig, Gerald R. Marx, Alexander Stork, S. Hegewisch-Becker, D. K. Hossfeld	2002	19
4	World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Annals of Oncology ·D. K. Hossfeld Hit paper breakdown →	2002	3614
5	Chronic lymphocytic leukaemia: risk-adapted therapy Annals of Oncology ·D. K. Hossfeld	2000	2
6	Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia Annals of Hematology ·Ulrich Dührsen, Bettina Hollwitz, (unknown), D. K. Hossfeld	1997	37
7	Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia by 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia Annals of Hematology ·H.J. Weh, Doris R. Seeger, I. Junge, D. K. Hossfeld	1996	9
8	Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH Cancer Chemotherapy and Pharmacology ·K. Mross, Andreas Hüttmann, Kenneth D. Herbst, A.-R. Hanauske, T. Schilling, C. Manegold, K. Burk, D. K. Hossfeld	1996	16
9	Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia by 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia Annals of Hematology ·H.J. Weh, Doris R. Seeger, I. Junge, D. K. Hossfeld	1996	1
10	Phase I Clinical and Pharmacokinetic Study of LU103793 (Cemadotin Hydrochloride) as an Intravenous Bolus Injection in Patients with Metastatic Solid Tumors Oncology Research and Treatment ·K. Mross, Katrina Herbst, W.E. Berdel, A. Korfel, I.-M. von Broen, Y. Bankmann, D. K. Hossfeld	1996	14
11	Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma Annals of Oncology ·H.J. Weh, H. Wilke, Judith Dierlamm, U. Klaassen, R. Siegmund, H. J. Illiger, Andreas Schalhorn, E.D. Kreuser, U. Hilgenfeld, B. Steinke, William P. Weber, Oswald Burkhard, A Zöller, J. Pfitzner, R. Šubert, Richard M. Kriebel, D. K. Hossfeld	1994	65
12	Metastasectomy following Chemotherapy in Patients with Advanced Soft Tissue Sarcomas Oncology Research and Treatment ·H.J. Weh, C. Zornig, M.H. Hoffknecht, R. Schwarz, D. K. Hossfeld	1992	2
13	Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer. Journal of Clinical Oncology ·U. Gatzemeier, D. K. Hossfeld, R. Neuhauss, Martin Reck, W. Achterrath, Luigi Lenaz	1992	12
14	Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors Cancer Chemotherapy and Pharmacology ·K. Mross, K. Hamm, Wolfgang Schultze‐Seemann, K. Burk, D. K. Hossfeld	1992	5
15	Jodo-Doxorubicin, ein neues Anthrazyklin-Derivat Oncology Research and Treatment ·K. Mross, T. Langenbuch, K. Burk, D. K. Hossfeld	1990	0
16	Chemotherapy of Metastatic Soft Tissue Sarcoma with a Combination of Adriamycin and DTIC or Adriamycin and Ifosfamide Oncology Research and Treatment ·H.J. Weh, M. Zügel, D. Wingberg, R. Schwarz, C. Zornig, M Dietel, D. K. Hossfeld	1990	12
17	Neutrophilic leukemia accompanied by hemorrhagic diathesis: Report of two cases Annals of Hematology ·D. K. Hossfeld, H. W. Lokhorst, M. Garbrecht	1987	15
18	Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome by Low Dose Cytosine Arabinoside Hämatologie und Bluttransfusion ·H.J. Weh, R. Zschaber, A. von Paleske, D. K. Hossfeld	1985	2
19	Translocation t (4; 11) in acute lymphocytic leukemia (ALL) Annals of Hematology ·H.J. Weh, D. K. Hossfeld	1982	11
20	A subtype of the prototypic karyotype in acute myeloid leukemia t (8; 21) (q22; q22), del 9 (q13; q23) Annals of Hematology ·D. K. Hossfeld, M. Higi, Sabine K�hler, Allison N. Miller, R. Zschaber	1980	11

About D. K. Hossfeld

D. K. Hossfeld is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Hepatology, having authored 54 papers that have together received 4.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Vascular Tumors and Angiosarcomas (7 papers), Sarcoma Diagnosis and Treatment (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (4 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Genetics (1.4k citations), Pathology and Forensic Medicine (2.3k citations), Hematology (1.2k citations), Oncology (1.6k citations) and Dermatology (332 citations). D. K. Hossfeld has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Walter Fiedler, H.J. Weh, Ulrich Dührsen, C. G. Schmidt, G. Landbeck, K. Mross, H. Kabisch, Holger Diedrichs, K. Höffken and Judith Dierlamm. Their work appears in journals such as Annals of Hematology, Annals of Oncology, Journal of Clinical Oncology, British Journal of Haematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact